WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.
Overactive immune response disrupts brain function before neuronal damage occurs. Tracking urea levels and nerve cell markers ...